Option 02-1

Posts in OncoBEAM Kit

Kobe, Japan, 2020.08.03 – Sysmex Corporation (Chairman and CEO: Hisashi letsugu) announced today that it has received approval for insurance coverage for blood-based RAS gene mutation testing for colorectal cancer using the OncoBEAM™ RAS CRC Kit. ...

Read More →

Subscribe for Blog Updates

We take your privacy seriously, and you may opt-out at any time

* indicates required
Contact Us